Volltextsuche nutzen
- versandkostenfrei ab € 30,–
- 6x in Wien und Salzburg
- 6 Mio. Bücher
- facultas
- Detailansicht
Recent Advances in the Pathophysiology of COPD
E-Book
(PDF mit drm)
(PDF mit drm)
160,67€
inkl. gesetzl. MwSt.
EPDF (mit DRM) sofort downloaden
Downloads sind nur in Österreich möglich!
Leitfaden zu E-Books
Downloads sind nur in Österreich möglich!
Leitfaden zu E-Books
In den Warenkorb
Click & Collect
Artikel online bestellen und in der Filiale abholen.
Derzeit in keiner facultas Filiale lagernd. Jetzt online bestellen!Artikel online bestellen und in der Filiale abholen.
Artikel in den Warenkorb legen, zur Kassa gehen und Wunschfiliale auswählen. Lieferung abholen und bequem vor Ort bezahlen.
Auf die Merkliste
Veröffentlicht 2012, von Peter J. Barnes, Trevor T. Hansel bei Birkhauser Basel
ISBN: 978-3-0348-7939-2
Reihe: Progress in Inflammation Research
Chronic obstructive pulmonary disease (COPD) ranges amongst the commonest diseases in the world. The relentless progression of the disease causes a pressing need for a better understanding of and therapies for COPD. This volume provides state-of-the-art information on the pathophysiology of COPD including an outlook on new therapies. It is of interest to researchers and clinicians in academia as ...
Beschreibung
Chronic obstructive pulmonary disease (COPD) ranges amongst the commonest diseases in the world. The relentless progression of the disease causes a pressing need for a better understanding of and therapies for COPD. This volume provides state-of-the-art information on the pathophysiology of COPD including an outlook on new therapies. It is of interest to researchers and clinicians in academia as well as in the pharmaceutical industry.
Chronic obstructive pulmonary disease (COPD) ranges amongst the commonest diseases in the world. The relentless progression of the disease causes a pressing need for a better understanding of and therapies for COPD. This volume provides state-of-the-art information on the pathophysiology of COPD including an outlook on new therapies. It is of interest to researchers and clinicians in academia as well as in the pharmaceutical industry.